Does INCLISIRAN Cause Peripheral arterial occlusive disease? 29 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Peripheral arterial occlusive disease have been filed in association with INCLISIRAN (LEQVIO). This represents 0.5% of all adverse event reports for INCLISIRAN.
29
Reports of Peripheral arterial occlusive disease with INCLISIRAN
0.5%
of all INCLISIRAN reports
0
Deaths
26
Hospitalizations
How Dangerous Is Peripheral arterial occlusive disease From INCLISIRAN?
Of the 29 reports, 26 (89.7%) required hospitalization.
Is Peripheral arterial occlusive disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INCLISIRAN. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does INCLISIRAN Cause?
Arthralgia (689)
Myalgia (518)
Injection site pain (488)
Low density lipoprotein increased (423)
Pain in extremity (417)
Pain (342)
Fatigue (325)
Drug ineffective (318)
Diarrhoea (309)
Dyspnoea (297)
What Other Drugs Cause Peripheral arterial occlusive disease?
NILOTINIB (319)
METHOTREXATE (120)
ADALIMUMAB (116)
RIVAROXABAN (101)
PONATINIB (90)
IMATINIB (86)
ASPIRIN (77)
ATORVASTATIN (70)
METOPROLOL (70)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)
Which INCLISIRAN Alternatives Have Lower Peripheral arterial occlusive disease Risk?
INCLISIRAN vs INCOBOTULINUMTOXINA
INCLISIRAN vs INDACATEROL
INCLISIRAN vs INDAPAMIDE
INCLISIRAN vs INDAPAMIDE\PERINDOPRIL
INCLISIRAN vs INDAPAMIDE\PERINDOPRIL ARGININE